CONMED Corporation Announces Quarterly Cash Dividend

Rhea-AI Summary

CONMED Corporation (NYSE: CNMD) has declared a quarterly cash dividend of $0.20 per share, payable on October 5, 2022, to shareholders on record as of September 15, 2022. This financial move reinforces the company's commitment to returning value to its shareholders. CONMED specializes in surgical devices and equipment for minimally invasive procedures across various medical specialties.

Positive

• Quarterly cash dividend of $0.20 per share demonstrates commitment to shareholder returns.

Negative

• Risks from COVID-19 pandemic affecting surgeries and hospital operations. Potential disruptions to supply chains.

LARGO, Fla.--(BUSINESS WIRE)-- CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on October 5, 2022 to all shareholders of record as of September 15, 2022.

About CONMED Corporation

CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company’s products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. For more information, visit www.conmed.com.

Forward-Looking Statements

This press release may contain forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. For example, in addition to general industry and economic conditions, factors that could cause actual results to differ materially from those in the forward-looking statements may include, but are not limited to, the risks posed to the Company’s business, financial condition, and results of operations by the COVID-19 global pandemic and the various government and other responses to the pandemic, including deferral of surgeries, reductions in hospital and ambulatory surgery center operating volumes, disruption to potential supply chain reliability, as well as the risk factors discussed in the Company's Annual Report on Form 10-K for the full year ended December 31, 2021 and listed under the heading Forward-Looking Statements in the Company’s most recently filed Form 10-Q. Any and all forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company’s performance on a going-forward basis. The Company believes that all forward-looking statements made by it have a reasonable basis, but there can be no assurance that management’s expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220811005686/en/

CONMED Corporation

Todd Garner

Chief Financial Officer

727-214-2975

ToddGarner@conmed.com

Source: CONMED Corporation

FAQ

What is the dividend amount for CNMD in October 2022?

CONMED Corporation has declared a dividend amount of $0.20 per share, payable on October 5, 2022.

When is the record date for CNMD's dividend?

The record date for CONMED's dividend is September 15, 2022.

How often does CNMD pay dividends?

CONMED Corporation pays dividends quarterly.

What risks could affect CNMD's future performance?

Potential risks include impacts from the COVID-19 pandemic, deferral of surgeries, and supply chain disruptions.